Effectiveness of Sympathetic Plexus Block on Male Pelvic Pain (Prostatitis, Prostatodynia)
SuspendedPhase 4NCT00194636
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to investigate, by means of a temporary sympathetic nerve block, the involvement of the sympathetic nervous system in Chronic Pelvic Pain Syndrome (CPPS). This study may also result in a new therapeutic approach for male CPPS.
Study details
- Official title
- Effectiveness 0f Sympathetic Plexus Block on Male Pelvic Pain (Prostatitis, Prostatodynia)
- Conditions
- Chronic Male Pelvic Pain Syndrome
- Prostatitis
- Interventions
- Sponsor
- University of Washington
- Collaborators
- Paul G. Allen Family Foundation
- Start date
- 2003-11
- Sex
- Male
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Men with Chronic Pelvic Pain Syndrome who, for the past year, have not responded to standard pain treatment modalities. Exclusion Criteria: * Urinary tract infection with common pathogens * Treatment for prostate, bladder, renal, or other urinary malignancies. * Back pain or rectal pain only * Psychotic or suicidal men * Post-surgical pain * Pain from another source in genital the tract such as kidney stones or neoplasm * Having had radiation therapy * History of genitourinary tuberculosis * Neurological abnormalities such as stroke, brain tumors, spinal tumors, spinal cord injury and Parkinson's or Alzheimer's disease. * Drug allergies * Use of any drugs, such as antihypertensives, that would interfere with biochemical and electrodiagnostic tests. * Bleeding and clotting disorders such as factor deficiencies or anticoagulant drug use.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00194636